Smell dysfunction: a biomarker for COVID‐19

By S. T. Moein, S. Hashemian, Babak Mansourafshar, Ali Khorram-Tousi, P. Tabarsi, R. Doty. International Forum of Allergy and Rhinology, 2020

757 citations recorded by the source corpus.

Severe acute respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2), the virus that causes coronavirus disease 2019 (COVID‐19), is responsible for the largest pandemic since the 1918 influenza A virus subtype H1N1 influenza outbreak. The symptoms presently recognized by the World Health Organization are cough, fever, tiredness, and difficulty breathing. Patient‐reported smell and taste loss has been associated with COVID‐19 infection, yet no empirical olfactory testing on a cohort of COVID‐19 patients has been performed.

Subfields: Biomedical Engineering, Neurology, Sensory Systems

View Paper: https://www.semanticscholar.org/paper/85572d2f9db1bae95ca3e80c64f75d192ce77271

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Ferran Hueto
2. Jordi Laguarta
3. Brian Subirana
4. R. Aftab

Citations in the corpus

• Coronavirus (COVID-19) (2020, background): “• Anosmia and dysgeusia (loss of smell and taste; 85% moderate/severe or anosmic) [67]”
• COVID-19 Artificial Intelligence Diagnosis Using Only Cough Recordings (2020, methodology): “To address the modelling strategy, we were inspired by our research on Alzheimer’s[11] and the growing evidence of recently reported symptoms of COVID-19 patients who suffered neurological impairments such as temporary neuromuscular impairment and loss of smell during and post infection[12][13][14].”